A higher-dose flu vaccine may lower your risk of dementia
Older adults who received a high-dose flu shot were more likely to avoid dementia than those who got a standard dose. But is the vaccine itself doing the work, or do healthier habits explain the difference?
Researchers studying the link between vaccination and dementia risk keep running into the same wall: people who get vaccinated tend to be the same people who exercise more, eat better and visit their doctor regularly. So perhaps the vaccine is not doing anything at all, and it is simply the lifestyle that protects. A new study published on Fight Aging! tries to sidestep that problem by comparing doses against each other rather than comparing vaccinated people with unvaccinated ones.
The logic is elegant: if the effect were purely down to behaviour, a higher dose should add nothing extra. Someone who dutifully shows up at their GP for an annual flu shot does so regardless of whether they receive 15 micrograms or 60 micrograms of antigen. Yet the higher dose, a vaccine already available in the US for adults aged 65 and over, correlated with a significantly greater reduction in dementia risk. That points toward a genuine biological mechanism.
What happens in your body after a vaccine
The most widely discussed explanation is what immunologists call trained immunity: a kind of memory within the innate immune system that makes it sharper in responding to other triggers as well. Chronic inflammation in the brain, or neuroinflammation, plays a central role in the development of Alzheimer's disease and other forms of dementia. If vaccination damps down that background inflammation, it could slow the damage to neurons.
A stronger immune response from a higher dose would then deliver more of that protective effect. That is precisely what the data suggest. These are observational findings, not a randomised trial, but the study design makes the classic confounding factor of "healthy behaviour" far less plausible as an explanation.
How large is the effect, really?
That is the question that remains most difficult to answer. Studies linking flu vaccination to reduced dementia risk report figures ranging from a few percent to more than twenty percent in risk reduction, depending on the population studied and the methods used. That is an enormous spread. And even if the true effect sits at the lower end, it matters at a population level: dementia affects tens of millions of people worldwide and effective treatments are scarce.
The practical implication is real: the high-dose flu vaccine is not yet a standard recommendation for older adults in Europe, whereas it has been common practice in the US for years. Whether this research carries enough weight to shift that policy remains to be seen. What is becoming clearer is that flu vaccination may do more than prevent flu, and that the dose you receive could matter more than anyone previously assumed.